Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CRACC/SLAMF7 Antibody (MM0200-6G17) - Azide and BSA Free, Novus Biologicals™
SDP

Mouse Monoclonal Antibody

$206.50

Specifications

Antigen CRACC/SLAMF7
Clone MM0200-6G17
Concentration LYOPH
Dilution Flow Cytometry 1:20-100, CyTOF-ready
Applications Flow Cytometry, CyTOF
View More Specs

Products 2
Catalog Number Mfr. No. Quantity Price Quantity & Availability  
Catalog Number Mfr. No. Quantity Price Quantity & Availability  
NB019100
SDP
View Documents
Novus Biologicals
NBP2122060.025MG
0.025 mg
Each for $206.50
Only null left
Add to Cart
 
NBP212206
SDP
View Documents
Novus Biologicals
NBP212206
0.1 mg N/A N/A N/A
Description

Description

CRACC/SLAMF7 Monoclonal specifically detects CRACC/SLAMF7 in Human samples. It is validated for Flow Cytometry, CyTOF-ready.
Specifications

Specifications

CRACC/SLAMF7
LYOPH
Flow Cytometry, CyTOF
Unconjugated
Mouse
Human
19A, CD2 subset 1, CD2-like receptor activating cytotoxic cells, CD319, CD319 antigen, CRACCCD2-like receptor-activating cytotoxic cells, CS119A24 protein, Membrane protein FOAP-12, Novel Ly9, novel LY9 (lymphocyte antigen 9) like protein, Protein 19A, SLAM family member 7
SLAMF7
Primary
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
MM0200-6G17
Flow Cytometry 1:20-100, CyTOF-ready
Monoclonal
Purified
RUO
Q9NQ25
57823
IgG2
Protein G purified
Videos
SDS
Documents

Documents

Product Certifications

For Research Use Only

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.